Stocktoria
Voyager Therapeutics, Inc. VYGR
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2015-11-11
Chart by TradingView
1/9
Piotroski F — financial health
-1.03
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $40.4M | $80.0M | $250.0M | $40.9M | $37.4M |
| Operating income | -$131.8M | -$83.3M | $122.0M | -$50.8M | -$73.6M |
| Net income | -$119.7M | -$65.0M | $132.3M | -$46.4M | -$71.2M |
| Operating cash flow | -$132.5M | -$15.3M | $77.9M | -$12.5M | -$53.5M |
| Free cash flow | -$135.1M | -$18.8M | $74.7M | -$15.0M | -$55.1M |
| Total assets | $252.3M | $393.1M | $351.3M | $159.4M | $193.9M |
| Total liabilities | $56.2M | $93.3M | $115.0M | $100.3M | $98.8M |
| Shareholders' equity | $196.1M | $299.8M | $236.3M | $59.0M | $95.1M |
| Ratios | |||||
| Operating margin | -326.6% | -104.1% | 48.8% | -124.3% | -196.8% |
| Net margin | -296.5% | -81.3% | 52.9% | -113.4% | -190.3% |
| FCF margin | -334.5% | -23.5% | 29.9% | -36.7% | -147.4% |
| Return on assets | -47.5% | -16.5% | 37.7% | -29.1% | -36.7% |
| Return on equity | -61.1% | -21.7% | 56.0% | -78.6% | -74.9% |
| Current ratio | 7.64 | 5.56 | 4.96 | 1.72 | 2.68 |
| Revenue growth | -49.5% | -68.0% | 511.2% | 9.3% | -78.1% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 578,024 | $2.2M |
| Point72 Asset Management, L.P. | 268,223 | $1.0M |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -1.03 (distress)
- Working capital / assets 0.698
- Retained earnings / assets -1.767
- EBIT / assets -0.523
- Equity / liabilities 3.489
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001640266 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.